A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis

Corpechot, Christophe, Chazouillères, Olivier, Rousseau, Alexandra, Le Gruyer, Antonia, Habersetzer, François, Mathurin, Philippe, Goria, Odile, Potier, Pascal, Minello, Anne, Silvain, Christine, Abergel, Armand, Debette-Gratien, Maryline, Larrey, Dominique, Roux, Olivier, Bronowicki, Jean-Pierre, Boursier, Jérôme, de Ledinghen, Victor, Heurgue-Berlot, Alexandra, Nguyen-Khac, Eric, Zoulim, Fabien, Ollivier-Hourmand, Isabelle, Zarski, Jean-Pierre, Nkontchou, Gisèle, Lemoinne, Sara, Humbert, Lydie, Rainteau, Dominique, Lefèvre, Guillaume, de Chaisemartin, Luc, Chollet-Martin, Sylvie, Gaouar, Farid, Admane, Farid-Hakeem, Simon, Tabassome, Poupon, Raoul·2018·New England Journal of Medicine
DOI 10.1056/nejmoa1714519

Cited by (115)

Items 101–115 of 115

  1. PPAR-Mediated Bile Acid Glucuronidation: Therapeutic Targets for the Treatment of Cholestatic Liver Diseases
    Gallucci, Gina M., Hayes, Colleen M., Boyer, James L., Barbier, Olivier, Assis, David N., Ghonem, Nisanne S. · 2024 · Cells
  2. Obeticholic Acid for Primary Biliary Cholangitis
    Floreani, Annarosa, Gabbia, Daniela, De Martin, Sara · 2022 · Biomedicines
  3. Biochemical and plasma lipid responses to pemafibrate in patients with primary biliary cholangitis
    Joshita, Satoru, Umemura, Takeji, Yamashita, Yuki, Sugiura, Ayumi, Yamazaki, Tomoo, Fujimori, Naoyuki, Matsumoto, Akihiro, Tanaka, Eiji · 2019 · Hepatology Research
  4. Effects of Primary Biliary Cholangitis on Quality of Life and Health Care Costs in the United Kingdom
    Rice, Stephen, Albani, Viviana, Minos, Dimitrios, Fattakhova, Gulnar, Mells, George F., Carbone, Marco, Flack, Steven, Varvaropoulou, Nikoletta, Badrock, Jonathan, Spicer, Ann et al. · 2021 · Clinical Gastroenterology and Hepatology
  5. Functional and Structural Insights into Human PPARα/δ/γ Subtype Selectivity of Bezafibrate, Fenofibric Acid, and Pemafibrate
    Honda, Akihiro, Kamata, Shotaro, Akahane, Makoto, Machida, Yui, Uchii, Kie, Shiiyama, Yui, Habu, Yuki, Miyawaki, Saeka, Kaneko, Chihiro, Oyama, Takuji et al. · 2022 · International Journal of Molecular Sciences
  6. Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
    Hirschfield, Gideon M, Bowlus, Christopher L, Jones, David E J, Kremer, Andreas E, Mayo, Marlyn J, Tanaka, Atsushi, Andreone, Pietro, Jia, Jidong, Jin, Qinglong, Macías-Rodríguez, Ricardo U et al. · 2026 · The Lancet Gastroenterology & Hepatology
  7. Adjunct Fenofibrate Up‐regulates Bile Acid Glucuronidation and Improves Treatment Response For Patients With Cholestasis
    Gallucci, Gina M., Trottier, Jocelyn, Hemme, Christopher, Assis, David N., Boyer, James L., Barbier, Olivier, Ghonem, Nisanne S. · 2021 · Hepatology Communications
  8. A validation study of the Ursodeoxycholic Acid Response Score in Japanese patients with primary biliary cholangitis
    Yagi, Minami, Matsumoto, Kosuke, Komori, Atsumasa, Abe, Masanori, Hashimoto, Naoaki, Inao, Mie, Namisaki, Tadashi, Kawata, Kazuhito, Ninomiya, Masashi, Fujii, Hideki et al. · 2020 · Liver International
  9. Long-Term Efficacy and Safety of Selective PPARδ Agonist Seladelpar in Primary Biliary Cholangitis: ASSURE Interim Study Results
    Levy, Cynthia, Trivedi, Palak J., Kowdley, Kris V., Gordon, Stuart C., Bowlus, Christopher L., Londoño, Maria Carlota, Hirschfield, Gideon M., Gulamhusein, Aliya, Lawitz, Eric J., Vierling, John M. et al. · 2026 · American Journal of Gastroenterology
  10. Anti-Cholestatic Therapy with Obeticholic Acid Improves Short-Term Memory in Bile Duct-Ligated Mice
    Gee, Lucy M.V., Barron-Millar, Ben, Leslie, Jack, Richardson, Claire, Zaki, Marco Y.W., Luli, Saimir, Burgoyne, Rachel A., Cameron, Rainie I.T., Smith, Graham R., Brain, John G. et al. · 2023 · The American Journal of Pathology
  11. Effects of Switching from Fenofibrate to Pemafibrate for Asymptomatic Primary Biliary Cholangitis
    Dohmen, Kazufumi, Onohara, Shin-ya, Harada, Shigeru · 2021 · The Korean Journal of Gastroenterology
  12. Efficacy and safety of fenofibrate add-on therapy in patients with primary biliary cholangitis refractory to ursodeoxycholic acid: A retrospective study and updated meta-analysis
    Guoyun, Xuan, Dawei, Ding, Ning, Liu, Yinan, Hu, Fangfang, Yang, Siyuan, Tian, Hao, Sun, Jiaqi, Yang, Ang, Xu, Guanya, Guo et al. · 2022 · Frontiers in Pharmacology
  13. Treatment of Primary Biliary Cholangitis
    Liu, Chung-Heng, Bowlus, Christopher L. · 2022 · Clinics in Liver Disease
  14. Second-Line Therapies in Primary Biliary Cholangitis: A Comparative Review of Obeticholic Acid, Fibrates, Seladelpar, and Elafibranor
    Jamal, Fares, Elshaer, Amani, Alatout, Mayar H., Odeh, Nour B., Youssef, Amal, Abo Abdullah, Humam, Elmasry, Sandra, Shahin, Tala, Abdul Nabi, Hussein, Worden, Astin R. et al. · 2025 · Biomedicines
  15. Advancing care in primary biliary cholangitis: emerging insights and novel therapies
    Vögelin, Marius, Kremer, Andreas E. · 2025 · Expert Opinion on Pharmacotherapy